Palisade Bio (PALI) Total Non-Current Liabilities (2012 - 2026)

Palisade Bio (PALI) has 15 years of Total Non-Current Liabilities data on file, last reported at $5.7 million in Q1 2026.

• On a quarterly basis, Total Non-Current Liabilities rose 98.88% year-over-year to $5.7 million in Q1 2026; TTM through Mar 2026 was $5.7 million, a 98.88% increase from a year earlier, with the FY2025 full-year figure at $4.7 million, up 45.09% from the prior year.
• Total Non-Current Liabilities for Q1 2026 stood at $5.7 million, up from $4.7 million in the prior quarter.
• Over the last five years, Total Non-Current Liabilities for PALI reached as high as $5.7 million in Q1 2026 and fell as low as $1.5 million in Q1 2023.
• Historically, Total Non-Current Liabilities has averaged $3.2 million across 5 years, with a median of $2.9 million in 2024.
• Across the five-year window, Total Non-Current Liabilities decreased 26.09% in 2023 and soared 98.88% in 2026, its largest moves.
• Year by year, Total Non-Current Liabilities stood at $3.3 million in 2022, then retreated by 16.66% to $2.7 million in 2023, then advanced by 18.3% to $3.2 million in 2024, then surged by 45.09% to $4.7 million in 2025, then advanced by 20.95% to $5.7 million in 2026.
• Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $5.7 million in Q1 2026, $4.7 million in Q4 2025, and $3.8 million in Q3 2025.